Ashley Marie Nelson, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cell Transplantation | 16 | 2024 | 5425 | 1.730 |
Why?
|
| Quality of Life | 25 | 2024 | 12730 | 0.980 |
Why?
|
| Fatigue | 7 | 2022 | 1526 | 0.680 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 5 | 2022 | 689 | 0.670 |
Why?
|
| Pelvic Exenteration | 1 | 2018 | 22 | 0.660 |
Why?
|
| Anxiety | 10 | 2022 | 4279 | 0.610 |
Why?
|
| Interleukin-10 | 1 | 2023 | 1200 | 0.610 |
Why?
|
| Depression | 13 | 2024 | 7733 | 0.580 |
Why?
|
| Adaptation, Psychological | 9 | 2024 | 2575 | 0.500 |
Why?
|
| Hematologic Neoplasms | 7 | 2024 | 1820 | 0.500 |
Why?
|
| Palliative Care | 5 | 2021 | 3478 | 0.480 |
Why?
|
| Genital Neoplasms, Female | 1 | 2018 | 516 | 0.440 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2022 | 3497 | 0.410 |
Why?
|
| Graft vs Host Disease | 1 | 2024 | 2951 | 0.390 |
Why?
|
| Androgen Antagonists | 2 | 2017 | 1350 | 0.380 |
Why?
|
| Caregivers | 6 | 2023 | 2074 | 0.370 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 3 | 2022 | 997 | 0.290 |
Why?
|
| Terminal Care | 3 | 2021 | 1688 | 0.250 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2022 | 9185 | 0.250 |
Why?
|
| Neoplasms | 8 | 2022 | 21596 | 0.240 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 2022 | 1379 | 0.240 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 3915 | 0.240 |
Why?
|
| Sleep | 2 | 2021 | 4604 | 0.230 |
Why?
|
| Transplantation Conditioning | 2 | 2017 | 1597 | 0.170 |
Why?
|
| Middle Aged | 25 | 2024 | 213127 | 0.160 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2022 | 703 | 0.160 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2022 | 290 | 0.160 |
Why?
|
| Models, Biological | 1 | 2014 | 9581 | 0.150 |
Why?
|
| Humans | 41 | 2024 | 742088 | 0.150 |
Why?
|
| Loneliness | 1 | 2019 | 184 | 0.150 |
Why?
|
| Prostatic Neoplasms | 2 | 2017 | 11039 | 0.140 |
Why?
|
| Self Efficacy | 1 | 2020 | 610 | 0.140 |
Why?
|
| Antiemetics | 1 | 2018 | 176 | 0.140 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2022 | 1255 | 0.130 |
Why?
|
| Pilot Projects | 3 | 2024 | 8297 | 0.130 |
Why?
|
| Social Perception | 1 | 2019 | 424 | 0.130 |
Why?
|
| Male | 23 | 2024 | 349538 | 0.130 |
Why?
|
| Nausea | 1 | 2018 | 665 | 0.130 |
Why?
|
| Vomiting | 1 | 2018 | 632 | 0.130 |
Why?
|
| Aged | 15 | 2023 | 162944 | 0.120 |
Why?
|
| Female | 24 | 2024 | 379592 | 0.120 |
Why?
|
| Transplantation, Homologous | 3 | 2019 | 4771 | 0.120 |
Why?
|
| Hospice Care | 1 | 2021 | 671 | 0.120 |
Why?
|
| Actigraphy | 1 | 2017 | 488 | 0.120 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2017 | 357 | 0.120 |
Why?
|
| Social Support | 2 | 2022 | 2117 | 0.120 |
Why?
|
| Qualitative Research | 2 | 2022 | 2680 | 0.120 |
Why?
|
| Interleukin-6 | 1 | 2023 | 3199 | 0.110 |
Why?
|
| Postoperative Period | 1 | 2018 | 1839 | 0.110 |
Why?
|
| Social Stigma | 1 | 2019 | 698 | 0.110 |
Why?
|
| Transplantation, Autologous | 1 | 2017 | 2123 | 0.110 |
Why?
|
| Stem Cell Transplantation | 1 | 2021 | 1618 | 0.100 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2023 | 1596 | 0.100 |
Why?
|
| Fear | 1 | 2020 | 1436 | 0.100 |
Why?
|
| Interviews as Topic | 1 | 2018 | 2536 | 0.100 |
Why?
|
| Restless Legs Syndrome | 1 | 2014 | 228 | 0.100 |
Why?
|
| Survivors | 1 | 2021 | 2286 | 0.100 |
Why?
|
| Spirituality | 1 | 2014 | 405 | 0.090 |
Why?
|
| Mouth Neoplasms | 1 | 2015 | 601 | 0.090 |
Why?
|
| Adult | 15 | 2022 | 213712 | 0.090 |
Why?
|
| Needs Assessment | 1 | 2015 | 1146 | 0.090 |
Why?
|
| Cognition | 3 | 2022 | 6722 | 0.080 |
Why?
|
| Family | 1 | 2020 | 3144 | 0.080 |
Why?
|
| Cytokines | 1 | 2023 | 7317 | 0.080 |
Why?
|
| Health Services Needs and Demand | 1 | 2015 | 1411 | 0.080 |
Why?
|
| Sexual Behavior | 1 | 2017 | 2050 | 0.080 |
Why?
|
| Self Report | 1 | 2017 | 3548 | 0.070 |
Why?
|
| Cognition Disorders | 1 | 2019 | 4030 | 0.060 |
Why?
|
| Survival Rate | 1 | 2018 | 12773 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2019 | 4229 | 0.060 |
Why?
|
| Cross-Sectional Studies | 5 | 2024 | 24913 | 0.060 |
Why?
|
| Patient Satisfaction | 1 | 2015 | 3391 | 0.060 |
Why?
|
| Young Adult | 5 | 2022 | 56350 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2018 | 6540 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 11472 | 0.050 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2014 | 1808 | 0.050 |
Why?
|
| Treatment Outcome | 4 | 2022 | 62966 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2020 | 6754 | 0.050 |
Why?
|
| Translations | 1 | 2019 | 64 | 0.040 |
Why?
|
| Inflammation | 1 | 2019 | 10578 | 0.040 |
Why?
|
| Pituitary-Adrenal System | 1 | 2022 | 553 | 0.040 |
Why?
|
| Factor Analysis, Statistical | 1 | 2019 | 975 | 0.040 |
Why?
|
| Death | 1 | 2021 | 675 | 0.030 |
Why?
|
| Perception | 1 | 2022 | 1188 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2022 | 5522 | 0.030 |
Why?
|
| Geriatric Assessment | 1 | 2023 | 1369 | 0.030 |
Why?
|
| Uncertainty | 1 | 2020 | 725 | 0.030 |
Why?
|
| Risk Factors | 3 | 2018 | 72145 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 13019 | 0.030 |
Why?
|
| Nitriles | 1 | 2018 | 952 | 0.030 |
Why?
|
| Sexual Partners | 1 | 2017 | 730 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 39004 | 0.030 |
Why?
|
| Prognosis | 2 | 2022 | 29010 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 57683 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2020 | 6452 | 0.020 |
Why?
|
| Physical Therapy Modalities | 1 | 2014 | 547 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 1889 | 0.020 |
Why?
|
| Psychometrics | 1 | 2019 | 2999 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2019 | 6891 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2018 | 1970 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2021 | 3014 | 0.020 |
Why?
|
| Internet | 1 | 2019 | 3062 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2022 | 7901 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2018 | 2933 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2019 | 6974 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2022 | 53187 | 0.020 |
Why?
|
| Psychotherapy | 1 | 2014 | 1644 | 0.020 |
Why?
|
| Child | 2 | 2022 | 77478 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 5304 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2021 | 77098 | 0.010 |
Why?
|
| Pandemics | 1 | 2022 | 8328 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 19862 | 0.010 |
Why?
|
| Age Factors | 1 | 2017 | 18355 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2017 | 21719 | 0.010 |
Why?
|
| Prevalence | 1 | 2015 | 15194 | 0.010 |
Why?
|
| Pregnancy | 1 | 2019 | 29087 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 15530 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 13655 | 0.010 |
Why?
|
| Hospitalization | 1 | 2014 | 10232 | 0.010 |
Why?
|